NCT03350178View on ClinicalTrials.gov

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

PHASE2TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

February 19, 2019

Study Completion Date

February 19, 2019

Conditions

Intensive Care UnitsFecal Microbiota Transplantation

Interventions

DRUG

fecal microbiota transfer

transfer of fecal microbiota from healthy donor to the patients

Trial Locations (2)

75018

Bichat Hospital, Paris

Unknown

Salengro hospital, Lille

Sponsors

Lead Sponsor

All Listed Sponsors

lead

MaaT Pharma

INDUSTRY